Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $57 at Baird
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $14.64 --0%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 18
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 18
Join SI Premium – FREE
Baird analyst Brian Skorney lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $57.00 (from $60.00) while maintaining a Outperform rating.
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Biohaven Pharma (BHVN) PT Raised to $19 at Morgan Stanley
- Veeva Systems (VEEV) PT Raised to $275 at Stifel on Expected Q2 Outperformance
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
